Cystic Fibrosis Canada and iMD Health Global announce partnership to provide credible health resources into the hands of care providers and their patients across Canada.
Cystic Fibrosis Canada is pleased to announce an important partnership with iMD Health Global (iMD), a CloudMD Software & Services company focused on health education, to provide credible resources regarding cystic fibrosis on the iMD platform. This partnership provides increased access to thousands of healthcare providers and patients wanting to better understand the standards of cystic fibrosis (CF) care.
“iMD’s platform will allow healthcare providers to be able to access our most recent Canadian cystic fibrosis guidelines and standards of care with ease,” said Dr. John Wallenburg, Chief Scientific Officer at Cystic Fibrosis Canada. “We are thrilled that these guidelines and other educational resources will now be available through iMD, improving access, communication and understanding for care providers and their patients living with cystic fibrosis.”
iMD Health is the largest digital health educational platform in Canada. iMD offers innovative technology that facilitates meaningful dialogue between healthcare professionals and patients inside the examination room, hospital bedsides, pharmacy consultations and during virtual consultations. iMD's award winning platform enables healthcare professionals to instantly access over 110,000 educational graphics, videos and resources at the point of care, across Canada.
“We are excited to collaborate with Cystic Fibrosis Canada in order to provide our healthcare providers with trusted resources to help them better manage their patients living with cystic fibrosis” said Jared Sonnenberg, Vice President of iMD, citing the need for accurate, reliable health information, particularly given the shift toward digital tools incited by the pandemic. “We are pleased our Users with better access to information regarding cystic fibrosis in a time when it is crucial to be properly informed.”
Through a resource like iMD, full of user-friendly and visually appealing information, healthcare providers and their patients will gain a better understanding of cystic fibrosis.
About Cystic Fibrosis Canada
Cystic Fibrosis Canada has dramatically changed the cystic fibrosis story. We have advanced research and care that has more than doubled life expectancy. Since being founded by parents in 1960, Cystic Fibrosis Canada has grown into a leading organization with a central role engaging people living with cystic fibrosis, parents and caregivers, volunteers, researchers and healthcare professionals, government and donors. We work together to change lives for the 4,344 Canadian children and adults living with cystic fibrosis through treatments, research, information and support. Despite our remarkable progress together, we are not yet done. Not when half of the Canadians with cystic fibrosis who died in the past three years were under the age of 34. We will keep pushing, keep going further until all people with cystic fibrosis can and do experience everything life has to offer —and enjoy everything life has to offer. Learn more at www.cysticfibrosis.ca.
About iMD Health Global
iMD Health Global is a Toronto-based eHealth software development company, focused on innovating healthcare education. Since 2010, iMD has grown into Canada’s largest digital patient engagement platform. Centred “At The Point of Care” ®, healthcare professionals use iMD’s cloud-based platform (in clinic or virtual consults) to engage with their patients at a deeper level and optimize knowledge transfer surrounding a patient’s condition and treatment plan. This is done through the seamless integration of over 110,000 images, booklets, and video resources, (covering 2,100 medical topics) into an award-winning user interface that makes patient education both efficient and effective. At the end of a patient’s consult, a summary of all the discussed information can be emailed to the patient to review and continue their learning journey at home, improving their health literacy and adherence to their treatment plan. The iMD platform is utilized by over 10,000 practitioner’s (doctor’s, nurses and pharmacists in, clinics, hospitals, pharmacies, infusion clinics and in homecare settings. For more information please visit: www.imdhealth.com and https://app.imdhealth.com iMD Health is a subsidiary of CloudMD Software & Services (TSXV: DOC)
For more information, contact Jared Sonnenberg, VP firstname.lastname@example.org
CloudMD is digitizing the delivery of healthcare by providing a patient centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. Through CloudMD’s proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, educational resources and artificial intelligence (AI). CloudMD currently services a combined ecosystem of over 7,000 psychiatrists, approximately 4,500 therapists and counsellors, approximately 4,000 psychologists, over 22,000 family physicians, over 34,000 medical specialists, over 1,500 allied health professionals, over 500 clinics, and over 5 million individuals across North America. CloudMD’s Enterprise Health Solutions Division includes one of the top 4 Employee Assistance Programs in Canada and offers one comprehensive, digitally connected platform for corporations, insurers and advisors to better manage the health and wellness of their employees and customers. For more information visit: www.cloudmd.ca
For more information, contact Julia Becker, VP Investor Relations email@example.com